Home › Companies › AVIDITY BIOSCIENCES INC. › 2023-2024

AVIDITY BIOSCIENCES INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and AVIDITY BIOSCIENCES INC.’s Form 8-K, filed 2024-06-14 (Item 5.07 on EDGAR). Page generated 04 October 2026.

5Ballot items
173Asset managers
1,237Fund votes
2024-06-13Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore AVIDITY BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by AVIDITY BIOSCIENCES INC.

These tallies are AVIDITY BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-14 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

AVIDITY BIOSCIENCES INC. — official shareholder meeting results, meeting held 2024-06-13
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Carsten Boess	63,891,628	--	--	9,825,456	5,160,086	Majority: yes
Elect Director: Sarah Boyce	67,562,873	--	--	6,154,211	5,160,086	Majority: yes
Elect Director: Troy Wilson, Ph.D., J.D.	45,112,985	--	--	28,048,738	5,715,447	Majority: yes
Proposal 2: The ratification of the appointment of BDO USA, P.C.	78,738,268	81,366	57,536	--	0	Majority: yes
Proposal 3: The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in the proxy statement related to the 2024 Annual Meeting.	67,573,742	995,207	5,179,358	--	5,128,863	Passed

Source: AVIDITY BIOSCIENCES INC., Form 8-K, filed with the SEC on 2024-06-14 — read the filing on EDGAR.

How asset managers voted at the AVIDITY BIOSCIENCES INC. 2023-2024 meeting

Each item below shows how the 173 asset managers that disclosed a AVIDITY BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in the related proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 8 wordings of this item as funds reported it.

99% Passed · of votes cast

FOR 99%

FOR: 67,573,742AGAINST: 995,207

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Proposal 3: The approval, on an advisory basis, of the compensation of the Company's named executive officers as described in the proxy statement related to the 2024 Annual Meeting.”): 67,573,742 for, 995,207 against — passed, per its Form 8-K filed 2024-06-14 (Item 5.07). Of all 95,594,000 outstanding shares: 71% for, 1% against (72% of the company cast a for/against vote).

The 170 asset managers below cast 99.0% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 99%

FOR: 99.0%AGAINST: 1.0%ABSTAIN: 0.1%NOT VOTED: 0.0%

Largest asset managers voting on “To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset manager	For	Against	Vote
Fidelity	25,237,865	0	For
T. Rowe Price	17,831,836	0	For
RTW INVESTMENTS, LP	6,746,875	0	For
State Street	3,874,883	32,662	For
Vanguard	3,877,907	0	For
RA CAPITAL MANAGEMENT, L.P.	3,464,745	0	For
BlackRock	3,364,056	27,520	For
Artisan	3,318,830	0	For
Avoro Capital Advisors LLC	3,000,000	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,524,522	0	For
Wellington	1,138,034	0	For
Charles Schwab	1,100,152	0	For
Nuveen	1,077,323	0	For
TIAA	1,074,205	0	For
JPMorgan	984,778	0	For
Dimensional	691,259	0	For
Woodline Partners LP	685,666	0	For
5AM Venture Management, LLC	665,555	0	For
Northern Trust	579,404	3,450	For
ORBIMED ADVISORS LLC	372,886	0	For
BESSEMER INVESTMENT MANAGEMENT LLC	314,734	0	For
OLD WESTBURY FUNDS INC	314,734	0	For
American Century	0	313,934	Against
SILVERARC CAPITAL MANAGEMENT, LLC	271,464	0	For
Aberdeen	258,828	0	For

Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.

2. To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Carsten Boess

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%

FOR: 63,891,628WITHHELD: 9,825,456

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Carsten Boess”): 63,891,628 for, 9,825,456 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,594,000 outstanding shares: 67% for, 10% withheld (77% of the company cast a for/withheld vote).

The 62 asset managers below cast 100% of the shares they voted on this item FOR (28,594,691 for, 0 against).

FOR 88%12%

FOR: 28,594,691 (88.1%)ABSTAIN: 3,878,992 (11.9%)

Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset manager	For	Abstain	Vote
Fidelity	11,131,304	35,878	For
T. Rowe Price	7,920,339	0	For
Vanguard	3,766,989	0	For
BlackRock	0	1,622,447	Abstain
Artisan	1,457,894	0	For
State Street	1,349,905	17,971	For
TIAA	1,074,205	0	For
Charles Schwab	550,076	0	For
Dimensional	0	538,602	Abstain
OLD WESTBURY FUNDS INC	0	314,734	Abstain
Equitable	37,031	198,930	Abstain
JPMorgan	203,247	0	For
Brighthouse	182,149	19,645	For
Direxion Shares ETF Trust	0	180,994	Abstain
Global X	164,185	0	For
John Hancock	131,700	27,347	For
Hartford	158,697	0	For
American Century	0	156,967	Abstain
QUANTITATIVE MASTER SERIES LLC	0	137,879	Abstain
MoA Funds Corp	0	136,191	Abstain
Aberdeen	0	129,414	Abstain
AIG/SunAmerica	0	101,815	Abstain
Prudential/PGIM	69,167	0	For
Transamerica	68,728	0	For
Lincoln Financial	61,400	6,406	For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

3. To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Dr. Troy Wilson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

62% Majority: yes · of votes cast

FOR 62%WITHHELD 38%

FOR: 45,112,985WITHHELD: 28,048,738

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Troy Wilson, Ph.D., J.D.”): 45,112,985 for, 28,048,738 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,594,000 outstanding shares: 47.2% for, 29% withheld (77% of the company cast a for/withheld vote).

The 62 asset managers below cast 100% of the shares they voted on this item FOR (14,317,378 for, 0 against).

FOR 44%ABSTAIN 56%

FOR: 14,317,378 (44.1%)ABSTAIN: 18,156,305 (55.9%)

Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset manager	For	Abstain	Vote
Fidelity	11,131,304	35,878	For
T. Rowe Price	0	7,920,339	Abstain
Vanguard	0	3,766,989	Abstain
BlackRock	0	1,622,447	Abstain
Artisan	1,457,894	0	For
State Street	13,233	1,354,643	Abstain
TIAA	1,074,205	0	For
Charles Schwab	0	550,076	Abstain
Dimensional	0	538,602	Abstain
OLD WESTBURY FUNDS INC	0	314,734	Abstain
Equitable	0	235,961	Abstain
JPMorgan	203,247	0	For
Brighthouse	58,246	143,548	Abstain
Direxion Shares ETF Trust	0	180,994	Abstain
Global X	0	164,185	Abstain
John Hancock	22,682	136,365	Abstain
Hartford	158,697	0	For
American Century	0	156,967	Abstain
QUANTITATIVE MASTER SERIES LLC	0	137,879	Abstain
MoA Funds Corp	0	136,191	Abstain
Aberdeen	0	129,414	Abstain
AIG/SunAmerica	0	101,815	Abstain
Prudential/PGIM	46,001	23,166	For
Transamerica	0	68,728	Abstain
Lincoln Financial	0	67,806	Abstain

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

4. To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Sarah Boyce

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

92% Majority: yes · of votes cast

FOR 92%8%

FOR: 67,562,873WITHHELD: 6,154,211

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sarah Boyce”): 67,562,873 for, 6,154,211 withheld, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,594,000 outstanding shares: 71% for, 6% withheld (77% of the company cast a for/withheld vote).

The 62 asset managers below cast 100% of the shares they voted on this item FOR (30,792,173 for, 0 against).

FOR 95%

FOR: 30,792,173 (94.8%)ABSTAIN: 1,681,510 (5.2%)

Largest asset managers voting on “To elect three directors to serve as Class I directors for a three-year term expiring at the 2027 Annual Meeti” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset manager	For	Abstain	Vote
Fidelity	11,167,182	0	For
T. Rowe Price	7,920,339	0	For
Vanguard	3,766,989	0	For
BlackRock	1,622,447	0	For
Artisan	1,457,894	0	For
State Street	1,349,905	17,971	For
TIAA	1,074,205	0	For
Charles Schwab	550,076	0	For
Dimensional	0	538,602	Abstain
OLD WESTBURY FUNDS INC	0	314,734	Abstain
Equitable	235,961	0	For
JPMorgan	203,247	0	For
Brighthouse	182,149	19,645	For
Direxion Shares ETF Trust	0	180,994	Abstain
Global X	164,185	0	For
John Hancock	131,700	27,347	For
Hartford	158,697	0	For
American Century	0	156,967	Abstain
QUANTITATIVE MASTER SERIES LLC	137,879	0	For
MoA Funds Corp	0	136,191	Abstain
Aberdeen	129,414	0	For
AIG/SunAmerica	0	101,815	Abstain
Prudential/PGIM	69,167	0	For
Transamerica	68,728	0	For
Lincoln Financial	61,400	6,406	For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

5. To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 78,738,268AGAINST: 81,366

AVIDITY BIOSCIENCES INC.’s own tally for this item (“Proposal 2: The ratification of the appointment of BDO USA, P.C.”): 78,738,268 for, 81,366 against, per its Form 8-K filed 2024-06-14 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 95,594,000 outstanding shares: 82% for, 0.1% against (82% of the company cast a for/against vote).

The 62 asset managers below cast 99.9% of the shares they voted on this item FOR (32,471,599 for, 2,084 against).

FOR 99.9%

FOR: 32,471,599 (100.0%)AGAINST: 2,084 (0.0%)

Largest asset managers voting on “To ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal” at AVIDITY BIOSCIENCES INC., 2023-2024
Asset manager	For	Against	Vote
Fidelity	11,167,182	0	For
T. Rowe Price	7,920,339	0	For
Vanguard	3,766,989	0	For
BlackRock	1,622,447	0	For
Artisan	1,457,894	0	For
State Street	1,365,792	2,084	For
TIAA	1,074,205	0	For
Charles Schwab	550,076	0	For
Dimensional	538,602	0	For
OLD WESTBURY FUNDS INC	314,734	0	For
Equitable	235,961	0	For
JPMorgan	203,247	0	For
Brighthouse	201,794	0	For
Direxion Shares ETF Trust	180,994	0	For
Global X	164,185	0	For
John Hancock	159,047	0	For
Hartford	158,697	0	For
American Century	156,967	0	For
QUANTITATIVE MASTER SERIES LLC	137,879	0	For
MoA Funds Corp	136,191	0	For
Aberdeen	129,414	0	For
AIG/SunAmerica	101,815	0	For
Prudential/PGIM	69,167	0	For
Transamerica	68,728	0	For
Lincoln Financial	67,806	0	For

Showing the 25 largest of 62 asset managers. See all 62 in the interactive database.

Largest AVIDITY BIOSCIENCES INC. shareholders voting in 2023-2024

Ranked by the number of AVIDITY BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 95,594,000 shares outstanding at the time of that meeting.

Top AVIDITY BIOSCIENCES INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Fidelity	26.40%
2	T. Rowe Price	18.65%
3	RTW INVESTMENTS, LP	7.06%
4	State Street	4.09%
5	Vanguard	4.06%
6	RA CAPITAL MANAGEMENT, L.P.	3.62%
7	BlackRock	3.55%
8	Artisan	3.47%
9	Avoro Capital Advisors LLC	3.14%
10	GEODE CAPITAL MANAGEMENT, LLC	1.59%

Reported AVIDITY BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

AVIDITY BIOSCIENCES INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
FMR (Fidelity)	22.58%	13F
Vanguard Group	13.83%	13F
FMR LLC	13.10%	DEF14A
Entities affiliated with T. Rowe Price Associates, Inc.	10.10%	DEF14A
Entities affiliated with RTW Investments	9.99%	DEF14A
BlackRock	9.63%	13F
Entities affiliated with Avoro Capital Advisors LLC	8.97%	DEF14A
T. Rowe Price	7.77%	13F
Cowen Financial Products LLC	5.89%	13G
Bristol-Myers Squibb Company	5.31%	DEF14A

Percentages above are of 95,594,000 shares outstanding, as reported by AVIDITY BIOSCIENCES INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AVIDITY BIOSCIENCES INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At AVIDITY BIOSCIENCES INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 173 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,237 separate fund positions. On the most widely held item on that ballot — To consider and vote upon, on an advisory basis, the compensation of our named executive… — the proposal passed with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AVIDITY BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-14.

AVIDITY BIOSCIENCES INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.